arrow
J

Jacob N. Hunnicutt

GlaxoSmithKline
H指数:17
被引数:765

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patients achieving low lupus disease activity state, systemic lupus erythematosus disease control or remission showed lower rates of organ damage during longitudinal follow-up: analysis of the Hopkins Lupus Cohort

达到低狼疮疾病活动状态,系统性红斑狼疮疾病控制或缓解的患者在纵向随访期间显示较低的器官损伤发生率: 霍普金斯狼疮队列分析

2024-12-110
OAAI